neovacs (ALNEV:Euronext Paris)
Chief Executive Officer, Neovacs S.A.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Miguel Sieler serves as a Venture Partner at Truffle Capital. Mr. Sieler focuses on life sciences. Mr. Sieler has been Chief Executive Officer since October 17, 2013 and General Director since October 2013 at Neovacs S.A. Mr. Sieler served in various senior positions at Bayer Group from 1975 to 2008. He served as the Chief Executive Officer of Bayer Pharma from 1995 to 1998 and at Bayer Group from 1998 to 2008. Mr. Sieler serves as a Director at Nexity SA and Ethypharm ...
3-5, Impasse ReillePhone: 33 1 53 10 93 00
Paris, Ile-de-France 75014
Fax: 33 1 53 10 93 03
Board Members Memberships*
Director, Chairman of Compensation & Appointments Committee and Member of Audit & Accounts Committee
Eberhard Karls Universität Tübingen
Institut D’études Politiques De Paris
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|